ribavirin has been researched along with Blood Pressure, High in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, T; Boeker, KHW; Buggisch, P; C-Registry, GH; Günther, R; Hinrichsen, H; Klinker, H; Manns, MP; Mauss, S; Müller, T; Serfert, Y; Wiegand, J; Zeuzem, S | 1 |
| He, J; Huang, D; Li, J; Liang, W; Liu, L; Xia, Z; Xu, X; Zhao, Y | 1 |
| Chen, PC; King, YC; Lai, CH; Liu, CY; Yang, YH | 1 |
| Al-Tawfiq, JA; Dib, J; Memish, ZA; Momattin, H | 1 |
| Qadir, A | 1 |
| Gilani, N; Panetta, JD | 1 |
| Chin, HS; Kim, ET; Kim, LH; Lee, JI | 1 |
| Midena, E; Noventa, F; Sebastiani, G; Tempesta, D; Vujosevic, S | 1 |
| Cattaneo, D; Cheli, S; Clementi, E; Colella, E; Ferraris, L; Gervasoni, C; Milazzo, L | 1 |
| Abdel-Aziz, A; Besheer, T; Elbendary, A; Gad, Y; Mokbel, T; Mousa, N | 1 |
| Bai, Y; Cai, BQ; Cao, B; Li, LY; Li, TS; Liu, ZY; Lu, WX; Wang, MZ; Wang, Z; Xu, WB; Xu, ZJ; Zhu, YJ | 1 |
| Godoy Guerrero, M; Manteca González, R; Palacios Rodríguez, S; Salgado Ordóñez, F | 1 |
| Iino, S; Itoh, F; Kobayashi, Y; Koike, K; Nagase, Y; Okuse, C; Suzuki, M; Yasuda, K; Yotsuyanagi, H | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H | 1 |
| Bátyi, E; Szegedi, J | 1 |
2 trial(s) available for ribavirin and Blood Pressure, High
| Article | Year |
|---|---|
Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Fundus Oculi; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prevalence; Prospective Studies; Recombinant Proteins; Regression Analysis; Retinal Diseases; Retinal Hemorrhage; Ribavirin; Risk Factors; Time Factors | 2006 |
Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.
Topics: Adolescent; Adult; Age Factors; Aged; Diabetes Complications; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Refusal; Viral Load | 2007 |
13 other study(ies) available for ribavirin and Blood Pressure, High
| Article | Year |
|---|---|
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
Topics: 2-Naphthylamine; Acute Disease; Adult; Aged; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Fluorenes; Germany; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Hypertension; Imidazoles; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Pleural Effusion; Proline; Pyrrolidines; Registries; Renal Insufficiency, Chronic; Ribavirin; Ritonavir; RNA, Viral; Severity of Illness Index; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine | 2019 |
SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.
Topics: Aged; Antiviral Agents; Betacoronavirus; Blood Loss, Surgical; Blood Volume; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Extracorporeal Membrane Oxygenation; Fatal Outcome; Humans; Hypertension; Lung; Lung Transplantation; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Virus Shedding | 2020 |
Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Topics: Adult; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension; Incidence; Interferon-alpha; Male; Middle Aged; Retina; Retinal Diseases; Retinal Vessels; Retrospective Studies; Ribavirin; Risk Factors; Taiwan | 2018 |
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus; Coronavirus Infections; Critical Illness; Diabetes Mellitus; Female; Humans; Hypertension; Imipenem; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult | 2014 |
A Young Lady with Hypertension - Rare Presentation of a Common Disease.
Topics: Antiviral Agents; Blood Transfusion; Cryoglobulinemia; Female; Glomerulonephritis; Hepacivirus; Hepatitis C; Humans; Hypertension; Interferon-alpha; Kidney Diseases; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2015 |
Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection.
Topics: Adult; Aged; Antiviral Agents; Diabetes Mellitus; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retrospective Studies; Ribavirin; Risk Factors | 2009 |
Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C, Chronic; Humans; Hypertension; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retinal Diseases; Ribavirin; Risk Factors; Visual Acuity | 2009 |
Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
Topics: Adult; Antiviral Agents; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Drug Monitoring; Female; Health Care Costs; Hepatitis C, Chronic; Humans; Hypertension; Hypertensive Retinopathy; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Male; Mass Screening; Metabolic Syndrome; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors | 2012 |
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antiviral Agents; Cough; Drug Substitution; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Hypertension; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors | 2013 |
Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Topics: Adult; Antiviral Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Ribavirin; Risk Factors | 2013 |
[Clinical diagnosis, treatment and prognosis of elderly SARS patients].
Topics: Age Factors; Aged; Antiviral Agents; Diabetes Complications; Female; Humans; Hypertension; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Severe Acute Respiratory Syndrome | 2003 |
[Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon].
Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis | 2005 |
[Effectiveness of peg-interferon and ribavirin for hepatitis C in a patient with hypertension and diminished kidney function].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Renal Insufficiency, Chronic; Ribavirin; Treatment Outcome | 2008 |